Date Published:
2009 Nov 13

Publication Type:
Journal Article

Authors:

B.M. Ances
F. Vaida
D. Rosario
J. Marquie-Beck
R.J. Ellis
D.M. Simpson
D.B. Clifford
J.C. McArthur
I. Grant
A. McCutchan

Secondary:
AIDS

Volume:
23

Pagination:
2317-22

Issue:
17

PMID:
19823068

URL:
https://pubmed.ncbi.nlm.nih.gov/19823068

DOI:
10.1097/QAD.0b013e328332204e

Keywords:
Adult;Antiretroviral Therapy, Highly Active;CHARTER;Female;HIV Infections;Humans;Internal;Male;Metabolic Syndrome;Middle Aged;Peripheral Nervous System Diseases;Prospective Studies;Sensation Disorders

Abstract:
<p>OBJECTIVES: Sensory neuropathy is a common peripheral nerve complication of HIV infection and highly active antiretroviral therapy. Metabolic syndrome (MetS), a cluster of risk factors for atherosclerosis and microvascular disease, is associated with sensory neuropathy in HIV-uninfected (HIV-negative) persons. We examined whether MetS or its components predispose individuals to HIV-associated sensory neuropathy (HIV-SN).DESIGN: From a prospective multicenter cohort of 1556 HIV-positive patients, a subgroup (n = 130) with fasting laboratory tests and sensory neuropathy assessment was selected.METHODS: Sensory neuropathy was defined by symmetrically decreased reflexes or sensation loss in the legs. MetS was defined by presence of at least three risk factors: mean arterial pressure of at least 100 mmHg; triglycerides (TRGs) of at least 150 mg/dl and high-density lipoprotein cholesterol of less than 40 mg/dl for male patients, less than 50 mg/dl for female patients; body mass index of more than 25 kg/m; plasma glucose (GLU) of at least 100 mg/dl and self-reported diabetes mellitus type 2. Multivariate logistic regression examined the association between HIV-SN and MetS.RESULTS: After controlling for HIV-SN risk factors such as age, CD4 current, length of HIV infection, use of dideoxynucleoside reverse transcriptase inhibitors and protease inhibitors, MetS was not associated with HIV-SN (P = 0.72). However, when each MetS component was assessed, elevated TRG was a significant risk factor for HIV-SN. From the larger cohort, both diabetes mellitus type 2 (odds ratio = 1.4, P < 0.01) and elevated TRG (odds ratio = 1.4, P = 0.01) were risk factors for HIV-SN.CONCLUSION: The risk of HIV-SN was increased for diabetes mellitus type 2 and elevated TRG but not for other MetS components. Both increase the risk of sensory neuropathy in HIV-populations, but the mechanism(s) remains unclear.</p>